Case number 2018-2016
NeXtGen Biologics, Inc. v. Axolotl Biologix, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | NEXTGEN BIOLOGICS, INC. v. AXOLOTL BIOLOGIX, INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| May 22, 2019 | 47 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [608927] [JAB] [Entered: 05/22/2019 10:11 AM] (0) |
| Apr 15, 2019 | 46 | JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [599920] [PBC] [Entered: 04/15/2019 09:24 AM] (0) |
| Apr 1, 2019 | 45 | Submitted after ORAL ARGUMENT by Gerard Bencen for NeXtGen Biologics, Inc. and William J. Utermohlen for Axolotl Biologix, Inc. Panel: Judge: Newman , Judge: Mayer , Judge: Lourie. [596799] [JAB] [Entered: 04/01/2019 02:11 PM] (0) |
| Mar 22, 2019 | 44 | CORRECTED Response to notice of oral argument from the Appellant NeXtGen Biologics, Inc.. [594851] [18-2016] [Gerard Bencen] [Entered: 03/22/2019 09:32 AM] (0) |
| Mar 20, 2019 | 43 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [42], ERROR: Counsel may not designate half minutes for argument time. CORRECTION: Please promptly submit corrected response. [594141] [PBC] [Entered: 03/20/2019 10:38 AM] (0) |
| Mar 14, 2019 | 41 | Response to notice of oral argument from the Appellee Axolotl Biologix, Inc.. [592877] [18-2016] [William Utermohlen] [Entered: 03/14/2019 02:05 PM] (0) |
| Mar 14, 2019 | 42 | Response to notice of oral argument from the Appellant NeXtGen Biologics, Inc.. [592921] [18-2016] [Gerard Bencen] [Entered: 03/14/2019 03:20 PM] (0) |
| Feb 22, 2019 | 40 | NOTICE OF ORAL ARGUMENT. Panel: 1904D. Case scheduled Apr 01, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 03/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [588010] [JAB] [Entered: 02/22/2019 01:58 PM] (0) |
| Nov 26, 2018 | 39 | 6 paper copies of the Reply Brief [34] received from Appellant NeXtGen Biologics, Inc.. [567480] [CJF] [Entered: 11/26/2018 02:11 PM] (0) |
| Nov 7, 2018 | 38 | Notice from Appellee Axolotl Biologix, Inc. regarding conflicts with oral argument. None. Service: 11/07/2018 by email. [563274] [18-2016] [William Utermohlen] [Entered: 11/07/2018 01:49 PM] (0) |
| Nov 6, 2018 | 37 | Notice from Appellant NeXtGen Biologics, Inc. regarding conflicts with oral argument. Service: 11/06/2018 by email. [563123] [18-2016] [Gerard Bencen] [Entered: 11/06/2018 08:29 PM] (1) |
| Nov 6, 2018 | 36 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Axolotl Biologix, Inc. and Appellant NeXtGen Biologics, Inc.. Service: 11/06/2018 by email. [563120] [18-2016] [Gerard Bencen] [Entered: 11/06/2018 07:53 PM] (1) |
| Nov 2, 2018 | 35 | Notice to Advise of Scheduling Conflicts. Please advise of any scheduling conflicts during the upcoming court session months listed in the attached Notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [562254] [SJ] [Entered: 11/02/2018 01:06 PM] (1) |
| Oct 31, 2018 | 34 | REPLY BRIEF FILED for Appellant NeXtGen Biologics, Inc. [33]. Number of Pages: 9. Service: 10/31/2018 by email. The paper copies of the brief should be received by the court on or before 11/09/2018. [562252] [SJ] [Entered: 11/02/2018 01:04 PM] (14) |
| Oct 31, 2018 | 33 | TENDERED Title: REPLY BRIEF. Service: 10/31/2018 by email. [561794] [18-2016] [Gerard Bencen] [Entered: 10/31/2018 05:48 PM] (14) |
| Oct 29, 2018 | 32 | 6 paper copies of the Opening Response Brief [31] received from Appellee Axolotl Biologix, Inc.. [560919] [CJF] [Entered: 10/29/2018 12:13 PM] (0) |
| Oct 17, 2018 | 31 | BRIEF FILED for Appellee Axolotl Biologix, Inc. [30]. Number of Pages: 12. Service: 10/17/2018 by email. The paper copies of the brief should be received by the court on or before 10/30/2018. Appellant NeXtGen Biologics, Inc. reply brief is due 10/31/2018. [559387] [SJ] [Entered: 10/23/2018 09:13 AM] (20) |
| Oct 17, 2018 | 30 | TENDERED from Appellee Axolotl Biologix, Inc.. Title: RESPONSE BRIEF. Service: 10/17/2017 by email. [558225] [18-2016] [William Utermohlen] [Entered: 10/17/2018 04:19 PM] (20) |
| Oct 17, 2018 | 29 | Entry of appearance for Peter T. Ewald as of counsel for Appellee Axolotl Biologix, Inc.. Service: 10/17/2018 by email. [558081] [18-2016] [Peter Ewald] [Entered: 10/17/2018 01:05 PM] (2) |
| Oct 11, 2018 | 28 | 6 paper copies of the Corrected Opening Brief [27] received from Appellant NeXtGen Biologics, Inc.. [556442] [CJF] [Entered: 10/11/2018 03:55 PM] (0) |
| Oct 2, 2018 | 26 | 6 paper copies of the Corrected Joint Appendix Brief [21] received from Appellant NeXtGen Biologics, Inc.. [553999] [CJF] [Entered: 10/02/2018 10:30 AM] (0) |
| Oct 1, 2018 | 27 | CORRECTED BRIEF FILED for Appellant NeXtGen Biologics, Inc. [25]. Number of Pages: 12. Service: 10/01/2018 by email. The paper copies of the brief should be received by the court on or before 10/12/2018. [554748] [SJ] [Entered: 10/04/2018 09:04 AM] (25) |
| Oct 1, 2018 | 25 | TENDERED Title: CORRECTED OPENING BRIEF. Service: 10/01/2018 by email. [553642] [18-2016] [Gerard Bencen] [Entered: 10/01/2018 01:13 PM] (25) |
| Sep 24, 2018 | 24 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellant's motion [17] did not include a certificate of compliance. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [552157] [MJL] [Entered: 09/24/2018 04:11 PM] (0) |
| Sep 24, 2018 | 22 | ORDER filed. NeXtGen Biologics, Inc.'s motion for leave to file the opening brief out of time [17] is granted. A corrected brief that complies with this order must be filed within five business days. Service as of this date by the Clerk of Court. [552136] [MJL] [Entered: 09/24/2018 03:38 PM] (2) |
| Sep 24, 2018 | 23 | NOTICE OF NON-COMPLIANCE: The submission of Appellant NeXtGen Biologics, Inc., [18], is not in compliance with the rules of this court (see attached). Compliant document due 10/01/2018. Service as of this date by the Clerk of Court. [552149] [MJL] [Entered: 09/24/2018 03:53 PM] (1) |
| Sep 20, 2018 | 20 | TENDERED Title: CORRECTED JOINT APPENDIX. Service: 09/20/2018 by email. [551566] [18-2016] [Gerard Bencen] [Entered: 09/20/2018 11:30 PM] (329) |
| Sep 20, 2018 | 17 | MOTION of to extend the time to 09/10/2018 to file the September 7, 2018 to September 9, 2018. [Consent: not addressed]. Service: 09/20/2018 by email. [551563] [18-2016] [Gerard Bencen] [Entered: 09/20/2018 11:19 PM] (5) |
| Sep 20, 2018 | 18 | Proof of emailing Brief, Joint Appendix, Motion, and updated Motion for Appellant NeXtGen Biologics, Inc.. Service: 09/20/2018 by email. [551564] [18-2016]. This filing is non-compliant. See Doc. No. [23]. [Gerard Bencen] [Entered: 09/20/2018 11:25 PM] (2) |
| Sep 20, 2018 | 19 | TENDERED Title: CORRECTED OPENING BRIEF. Service: 09/20/2018 by email. [551565] [18-2016]. This brief is non-compliant. See Doc. No. [22]. [Gerard Bencen] [Entered: 09/20/2018 11:29 PM] (0) |
| Sep 20, 2018 | 21 | CORRECTED APPENDIX FILED for NeXtGen Biologics, Inc. [20]. Number of Pages: 329. Service: 09/20/2018 by email. The paper copies of the appendix should be received by the court on or before 10/01/2018. [552132] [MJL] [Entered: 09/24/2018 03:34 PM] (329) |
| Sep 13, 2018 | 16 | NOTICE OF NON-COMPLIANCE: The submission of Appellant NeXtGen Biologics, Inc., Opening Brief and Appendix [15], is not in compliance with the rules of this court (see attached). Compliant document due on 09/20/2018. Appellee Axolotl Biologix, Inc. brief is due 10/19/2018. Service as of this date by the Clerk of Court.[549470] [SJ] [Entered: 09/13/2018 11:52 AM] (2) |
| Sep 10, 2018 | 15 | TENDERED from Appellant NeXtGen Biologics, Inc.. Title: OPENING BRIEF. Service: 09/09/2018 by email. [548283] [18-2016] This document is non-compliant. See Doc. No. [16] [Gerard Bencen] [Entered: 09/09/2018 06:12 PM] (0) |
| Jul 9, 2018 | 14 | Certified list from the United States Patent and Trademark Office. Service: 07/09/2018 by email. Appellant's brief is due 09/07/2018. [534496] [CFT] [Entered: 07/09/2018 02:34 PM] (19) |
| Jun 13, 2018 | 13 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [12], ERROR: The contact information included on the entry of appearance (EOA) for Gerard H. Bencen does not match the information in the attorney's user account. CORRECTION: Pursuant to FCR 47.3(c)(1), please update as needed to ensure the contact information on the EOA and in the user account matches. Account information may be updated at www.pacer.gov, or counsel may file an amended EOA. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [529065] [CFT] [Entered: 06/13/2018 11:42 AM] (0) |
| Jun 13, 2018 | 12 | Entry of appearance for Gerard H. Bencen as principal counsel for Appellant NeXtGen Biologics, Inc.. Service: 06/12/2018 by email. [528992] [18-2016] [Gerard Bencen] [Entered: 06/13/2018 10:04 AM] (2) |
| Jun 13, 2018 | 11 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [8] filed by Appellant NeXtGen Biologics, Inc. in 18-2016 is not signed and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [528940] [CFT] [Entered: 06/13/2018 08:52 AM] (0) |
| Jun 12, 2018 | 10 | Docketing Statement for the Appellant NeXtGen Biologics, Inc.. Service: 06/12/2018 by email. [528920] [18-2016] [Gerard Bencen] [Entered: 06/12/2018 11:26 PM] (3) |
| Jun 12, 2018 | 9 | Certificate of Interest for the Appellant NeXtGen Biologics, Inc.. Service: 06/12/2018 by email. [528917] [18-2016] [Gerard Bencen] [Entered: 06/12/2018 11:04 PM] (3) |
| Jun 12, 2018 | 8 | Entry of appearance for Gerard H. Bencen as principal counsel for Appellant NeXtGen Biologics, Inc.. Service: 06/12/2018 by email. [528916] [18-2016] [Gerard Bencen] [Entered: 06/12/2018 11:03 PM] (0) |
| Jun 11, 2018 | 7 | Corrected Certificate of Interest for the Appellee Axolotl Biologix, Inc.. Service: 06/11/2018 by email, US mail. [528557] [18-2016] [William Utermohlen] [Entered: 06/11/2018 07:01 PM] (3) |
| Jun 11, 2018 | 6 | Amended Entry of appearance for William J. Utermohlen as principal counsel for Appellee Axolotl Biologix, Inc.. Service: 06/11/2018 by email, US mail. [528555] [18-2016] [William Utermohlen] [Entered: 06/11/2018 06:59 PM] (2) |
| Jun 11, 2018 | 5 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [2] and certificate of interest Document No. [3] filed by Appellee Axolotl Biologix, Inc. in 18-2016 are without proofs of service and therefore cannot be accepted for filing at this time. [CLERK'S NOTE: Statement 2 on the Certificate of Interest is incomplete. All statements must be answered, using "none" or "not applicable" if appropriate. Please ensure that the refiled documents are also text-searchable.] You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [528524] [CFT] [Entered: 06/11/2018 04:36 PM] (0) |
| Jun 11, 2018 | 4 | Docketing Statement for the Appellee Axolotl Biologix, Inc.. Service: 06/11/2018 by email, US mail. [528489] [18-2016] [William Utermohlen] [Entered: 06/11/2018 03:18 PM] (3) |
| Jun 11, 2018 | 3 | Certificate of Interest for the Appellee Axolotl Biologix, Inc.. Service: 06/11/2018 by email, US mail. [528488] [18-2016] [William Utermohlen] [Entered: 06/11/2018 03:16 PM] (0) |
| Jun 11, 2018 | 2 | Entry of appearance for William J. Utermohlen as principal counsel for Appellee Axolotl Biologix, Inc.. Service: 06/11/2018 by email, US mail. [528486] [18-2016] [William Utermohlen] [Entered: 06/11/2018 03:14 PM] (0) |
| May 29, 2018 | 1 | Appeal docketed. Received: 05/29/2018. [525077] Entry of Appearance due 06/12/2018. Certificate of Interest due 06/12/2018. Docketing Statement due 06/12/2018. Certified List due 07/09/2018. [CFT] [Entered: 05/29/2018 02:44 PM] (14) |
